The new year brings changes!

January 10, 2017

The end of 2016 has been marked by major changes in the leadership of the Cancer Research Society. After 8 years as President and Chief Executive Officer, Andy Chabot is leaving for a brand new project: a well-deserved retirement! Under Andy’s guidance, the Cancer Research Society witnessed a profound change, notably in terms of revenue diversification.

During his tenure, research investments also increased from $6.5 million in 2008 to $14.1 million in the last fiscal year.

Andy's successor, Max Fehlmann, will be taking over on January 16, 2017. A senior executive with more than several years of experience in management, financing and business development in the public and private sectors, Max founded the NEOMED Institute in 2012 and was its president until his recent departure from the company.

Dominic Pilla Martin Thibodeau Andy Chabot Max Fehlmann
Domenic Pilla
Past Chairman
of the Board
Martin Thibodeau
Chairman of
the Board
Andy Chabot
and Chief
Executive Officer

Max Fehlman
President and Chief
Executive Officer

Domenic Pilla, is also passing the torch; after five years of outstanding work as Chairman of the Board. Domenic is being replaced by Martin Thibodeau, President, Quebec Headquarters, RBC Royal Bank, who is no stranger to the Society. Martin has been a very active member of the Board of Directors since June 2013 and was involved in many projects, including the Urban BBQ™ for which he has been the Honorary Chairman since its inception in 2014.

»   For more details about the changes in the Society Leadership, read our press release.
»   For more details about the changes in the Board of Directors, read our press release.

About the Cancer Research Society

Founded in 1945, the Cancer Research Society is a national not-for-profit organization whose sole mission is to fund research on all types of cancer, thereby contributing to the advancement of science aimed at preventing, detecting, and treating this disease. The Society primarily supports basic research, which has resulted in several innovative discoveries. It also finances projects in environment-cancer, a field in which the Society is considered to have played a pioneering role in Canada. In addition, through its Next Generation of Scientists program, the Society provides young researchers with the opportunity to pursue their careers in Canada. This unique and innovative funding initiative serves to prevent an exodus of our best scientific minds.

For more information or for interview requests, contact:
Nathalie Giroux
Vice President and Chief Operating Officer
Cancer Research Society
514-861-9227, ext. 248